Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference The new mini-textbook by Kamps & Hoffmann PDF, 110 pages

Lung Cancer

Free Subscription 10.02.2020 1 Am J Clin Oncol 6 Anticancer Res 1 Arch Bronconeumol 1 BMJ 1 Br J Cancer 1 Cancer 1 Cancer Lett 1 Cancer Sci 1 Clin Exp Metastasis 1 Clin Lung Cancer 1 Eur J Cancer 2 Eur J Cardiothorac Surg 1 Eur Respir J 2 Int J Cancer 2 Int J Radiat Oncol Biol Phys 1 J Cancer Res Clin Oncol 1 J Clin Invest 1 J Surg Oncol 2 J Thorac Cardiovasc Surg 3 J Thorac Oncol 2 Lancet Oncol 2 Lung Cancer (Auckl) 1 N Engl J Med 3 Oncogene 2 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. BHANDARI S, Kumar R, Pham D, Gaskins J, et al
   Treatment Timing in Small Cell Lung Cancer, a National Cancer Database Analysis.
   Am J Clin Oncol. 2020 Jan 31. doi: 10.1097/COC.0000000000000676.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. NAKAMURA Y, Miyazaki K, Aiko N, Misumi Y, et al
   Efficacy of PD-1 Inhibitors in Older Non-small Cell Lung Cancer Patients.
   Anticancer Res. 2020;40:923-928.
   PubMed     Text format     Abstract available
   
   
3. CHANVORACHOTE P, Sriratanasak N, Nonpanya N
   C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target.
   Anticancer Res. 2020;40:609-618.
   PubMed     Text format     Abstract available
   
   
4. KITA Y, Go T, Nakashima N, Liu D, et al
   Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells.
   Anticancer Res. 2020;40:733-741.
   PubMed     Text format     Abstract available
   
   
5. IOANNIDIS G, Papadaki C, Lagoudaki E, Tzardi M, et al
   Messenger-RNA Expression of Five Gemcitabine Sensitivity-related Genes Predicting Outcome in Advanced-stage Non-small Cell Lung Cancer.
   Anticancer Res. 2020;40:901-913.
   PubMed     Text format     Abstract available
   
   
6. PEZZUTO A, Cappuzzo F, D'Arcangelo M, Ciccozzi M, et al
   Prognostic Value of p16 Protein in Patients With Surgically Treated Non-small Cell Lung Cancer; Relationship With Ki-67 and PD-L1.
   Anticancer Res. 2020;40:983-990.
   PubMed     Text format     Abstract available
   
   
7. NAKANO T, Go T, Nakashima N, Liu D, et al
   Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer.
   Anticancer Res. 2020;40:1007-1014.
   PubMed     Text format     Abstract available
   
   

   
   Arch Bronconeumol

8. CARRICO F, Alves RM, Luis F
   Foreign Body Aspiration Simulating Lung Cancer.
   Arch Bronconeumol. 2020 Feb 1. pii: S0300-2896(19)30624.
   PubMed     Text format    
   
   

   
   BMJ

9. TREASURE T
   Questioning the benefit of lung metastasectomy in colorectal cancer.
   BMJ. 2020;368:m264.
   PubMed     Text format    
   
   

   
   Br J Cancer

10. ACHA-SAGREDO A, Uko B, Pantazi P, Bediaga NG, et al
    Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis.
    Br J Cancer. 2020 Feb 5. pii: 10.1038/s41416-020-0742.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

11. TAKAHAMA T, Azuma K, Shimokawa M, Takeda M, et al
    Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
    Cancer. 2020 Feb 5. doi: 10.1002/cncr.32749.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

12. XIAO R, Ding C, Zhu H, Liu X, et al
    Suppression of asparagine synthetase enhances the antitumor potency of ART and artemalogue SOMCL-14-221 in non-small cell lung cancer.
    Cancer Lett. 2020 Jan 31. pii: S0304-3835(20)30049.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Sci

13. OSUMI H, Horiguchi H, Kadomatsu T, Tashiro K, et al
    Tumor cell-derived ANGPTL2 establishes a preference for glycolytic metabolism in lung cancer cells.
    Cancer Sci. 2020 Feb 3. doi: 10.1111/cas.14337.
    PubMed     Text format     Abstract available
    
    

    
    Clin Exp Metastasis

14. LEE SW, Kim YS, Sung SY, Kwak YK, et al
    Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis.
    Clin Exp Metastasis. 2020 Feb 1. pii: 10.1007/s10585-020-10022.
    PubMed     Text format     Abstract available
    
    

    
    Clin Lung Cancer

15. SHAH R, Lester JF
    Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.
    Clin Lung Cancer. 2019 Dec 20. pii: S1525-7304(19)30346.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

16. FELIP E, Ardizzoni A, Ciuleanu T, Cobo M, et al
    CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.
    Eur J Cancer. 2020;127:160-172.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cardiothorac Surg

17. OPITZ I, Patella M, Payrard L, Perentes JY, et al
    Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis.
    Eur J Cardiothorac Surg. 2020 Feb 3. pii: 5721431. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
18. YANG MZ, Hou X, Li JB, Cai JS, et al
    Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
    Eur J Cardiothorac Surg. 2020 Feb 4. pii: 5722182. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Eur Respir J

19. BERGHMANS T, Dingemans AM, Hendriks LEL, Cadranel J, et al
    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm.
    Eur Respir J. 2020;55.
    PubMed     Text format    
    
    

    
    Int J Cancer

20. BRASKY TM, Ray RM, Navarro SL, Schenk JM, et al
    Supplemental one-carbon metabolism related B vitamins and lung cancer risk in the Women's Health Initiative.
    Int J Cancer. 2020 Feb 6. doi: 10.1002/ijc.32913.
    PubMed     Text format     Abstract available
    
    
21. FIDLER-BENAOUDIA MM, Torre LA, Bray F, Ferlay J, et al
    Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries.
    Int J Cancer. 2020 Feb 5. doi: 10.1002/ijc.32809.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

22. PENG J, Pond G, Donovan E, Ellis PM, et al
    A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 29. pii: S0360-3016(19)34545.
    PubMed     Text format     Abstract available
    
    
23. GIULIANI ME, Robinson CG, Salama JK, Daly ME, et al
    Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;106:455-459.
    PubMed     Text format    
    
    

    
    J Cancer Res Clin Oncol

24. TAKADA K, Yoneshima Y, Tanaka K, Okamoto I, et al
    Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors.
    J Cancer Res Clin Oncol. 2020 Feb 5. pii: 10.1007/s00432-020-03146.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Invest

25. LIN M, Luo H, Liang S, Chen J, et al
    Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients.
    J Clin Invest. 2020 Feb 6. pii: 132712. doi: 10.1172/JCI132712.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

26. CROWN A, Rocha FG, Raghu P, Lin B, et al
    Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    J Surg Oncol. 2020;121:480-485.
    PubMed     Text format     Abstract available
    
    

    
    J Thorac Cardiovasc Surg

27. ZHENG R, Shen Q, Mardekian S, Solomides C, et al
    Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Dec 20. pii: S0022-5223(19)39883.
    PubMed     Text format     Abstract available
    
    
28. RANDHAWA SK, Puri V
    Commentary: The changing risk paradigm in lung cancer: Are we opening Pandora's box?
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43494.
    PubMed     Text format    
    
    

    
    J Thorac Oncol

29. COHEN D, Hondelink LM, Solleveld-Westerink N, Uljee SM, et al
    Optimizing mutation and fusion detection in Non-Small Cell Lung Cancer by sequential DNA and RNA sequencing.
    J Thorac Oncol. 2020 Jan 31. pii: S1556-0864(20)30093.
    PubMed     Text format     Abstract available
    
    
30. POIRIER JT, George J, Owonikoko TK, Berns A, et al
    New approaches to small cell lung cancer therapy : from the laboratory to the clinic.
    J Thorac Oncol. 2020 Feb 1. pii: S1556-0864(20)30056.
    PubMed     Text format     Abstract available
    
    
31. BACKMAN M, La Fleur L, Kurppa P, Djureinovic D, et al
    Characterization of patterns of immune cell infiltration in non-small cell lung cancer (NSCLC).
    J Thorac Oncol. 2020 Feb 3. pii: S1556-0864(20)30015.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

32. SEQUIST LV, Han JY, Ahn MJ, Cho BC, et al
    Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study.
    Lancet Oncol. 2020 Feb 3. pii: S1470-2045(19)30785.
    PubMed     Text format     Abstract available
    
    
33. SCHMID S, Fruh M, Peters S
    Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?
    Lancet Oncol. 2020 Feb 3. pii: S1470-2045(19)30859.
    PubMed     Text format    
    
    

    
    Lung Cancer (Auckl)

34. CHENG YY, Rath EM, Linton A, Yuen ML, et al
    The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer.
    Lung Cancer (Auckl). 2020;11:1-11.
    PubMed     Text format     Abstract available
    
    
35. GADGEEL S, Shaw AT, Barlesi F, Crino L, et al
    Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies.
    Lung Cancer (Auckl). 2019;10:125-130.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

36. RAMALINGAM SS, Vansteenkiste J, Planchard D, Cho BC, et al
    Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
    N Engl J Med. 2020;382:41-50.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

37. QI M, Dai D, Liu J, Li Z, et al
    AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.
    Oncogene. 2020 Jan 31. pii: 10.1038/s41388-020-1176.
    PubMed     Text format     Abstract available
    
    
38. TONG X, Wang S, Lei Z, Li C, et al
    MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-beta-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncogene. 2020 Feb 6. pii: 10.1038/s41388-020-1189.
    PubMed     Text format     Abstract available
    
    
39. REBOLLIDO-RIOS R, Venton G, Sanchez-Redondo S, Iglesias I Felip C, et al
    Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
    Oncogene. 2020 Feb 3. pii: 10.1038/s41388-020-1184.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

40. LI J, Li X, Zhang C, Zhang C, et al
    A signature of tumor immune microenvironment genes associated with the prognosis of nonsmall cell lung cancer.
    Oncol Rep. 2020 Jan 14. doi: 10.3892/or.2020.7464.
    PubMed     Text format     Abstract available
    
    
41. LI Y, Ma C, Qian M, Wen Z, et al
    [Retracted] Downregulation of NOB1 suppresses the proliferation and tumor growth of nonsmall cell lung cancer in vitro and in vivo.
    Oncol Rep. 2020 Jan 29. doi: 10.3892/or.2020.7483.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

42. LU J, Zang H, Zheng H, Zhan Y, et al
    Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
    PLoS One. 2020;15:e0227768.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: